PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-129.30%
Revenue decline while CRK shows 34.07% growth. Joel Greenblatt would examine competitive position erosion.
-193.49%
Cost reduction while CRK shows 16.84% growth. Joel Greenblatt would examine competitive advantage.
7.42%
Gross profit growth below 50% of CRK's 39.44%. Michael Burry would check for structural issues.
-466.66%
Margin decline while CRK shows 4.01% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
-12.41%
G&A reduction while CRK shows 33.65% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
-12.15%
Other expenses reduction while CRK shows 14.06% growth. Joel Greenblatt would examine efficiency.
-12.19%
Operating expenses reduction while CRK shows 16.77% growth. Joel Greenblatt would examine advantage.
-142.19%
Total costs reduction while CRK shows 16.78% growth. Joel Greenblatt would examine advantage.
19.35%
Interest expense growth less than half of CRK's 139.80%. David Dodd would verify sustainability.
-24.50%
D&A reduction while CRK shows 13.54% growth. Joel Greenblatt would examine efficiency.
9.64%
EBITDA growth below 50% of CRK's 40.94%. Michael Burry would check for structural issues.
-462.28%
EBITDA margin decline while CRK shows 4.86% growth. Joel Greenblatt would examine position.
110.61%
Operating income growth 1.25-1.5x CRK's 85.38%. Bruce Berkowitz would examine sustainability.
-818.88%
Operating margin decline while CRK shows 89.10% growth. Joel Greenblatt would examine position.
32.82%
Other expenses growth while CRK reduces costs. John Neff would investigate differences.
665.12%
Pre-tax income growth exceeding 1.5x CRK's 37.43%. David Dodd would verify competitive advantages.
-2711.62%
Pre-tax margin decline while CRK shows 53.33% growth. Joel Greenblatt would examine position.
-1627.78%
Both companies reducing tax expense. Martin Whitman would check patterns.
2444.00%
Net income growth exceeding 1.5x CRK's 46.17%. David Dodd would verify competitive advantages.
-8783.61%
Net margin decline while CRK shows 59.85% growth. Joel Greenblatt would examine position.
2720.00%
EPS growth exceeding 1.5x CRK's 46.43%. David Dodd would verify competitive advantages.
2720.00%
Diluted EPS growth exceeding 1.5x CRK's 46.43%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-0.03%
Diluted share reduction while CRK shows 0.83% change. Joel Greenblatt would examine strategy.